Breaking News Instant updates and real-time market news.

DVAX

Dynavax

, LVS

Las Vegas Sands

09:40
07/31/17
07/31
09:40
07/31/17
09:40

Unusually active option classes on open July 31st

Unusual total active option classes on open include: Dynavax (DVAX), Las Vegas Sands (LVS), Vale (VALE), Cliffs Natural (CLF), and Comcast (CMCSA).

DVAX

Dynavax

LVS

Las Vegas Sands

VALE

Vale

CLF

Cliffs Natural

CMCSA

Comcast

$39.52

0.09 (0.23%)

  • 31

    Jul

  • 07

    Aug

  • 10

    Aug

DVAX Dynavax

07/31/17
WBLR
07/31/17
NO CHANGE
WBLR
Outperform
Dynavax fair value estimate raised to $30 from $17 at William Blair
William Blair analyst Y. Katherine Xu raised her fair value estimate for Dynavax shares to $30 after an FDA panel voted 12-1 that the safety to date supports Heplisav approval for vaccination against hepatitis B infection in adults over 18 years old. The analyst believes the vote will lead to approval of Heplisav on its FDA action date of August 10. Dynavax's oncology candidates, if successful, could generate higher value than Heplisav for the shares, Xu tells investors in a research note. She keeps an Outperform rating on the name.
07/31/17
JPMS
07/31/17
UPGRADE
Target $27
JPMS
Overweight
Dynavax upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Dynavax to Overweight and raised his price target for the shares to $27 from $6. Following last week's FDA panel, the analyst now believes that hepatitis B vaccine Heplisav has a high probability of approval by the August 10 action date. He expects "rapid uptake" and sees $450M-plus in peak sales in the U.S. alone. Further, Rama believes SD-101 has compelling early-stage data in treatment-naive melanoma. The analyst views the asset as underappreciated.
07/31/17
RBCM
07/31/17
UPGRADE
RBCM
Outperform
Dynavax upgraded to Outperform from Sector Perform at RBC Capital
07/31/17
RBCM
07/31/17
UPGRADE
RBCM
Outperform
Dynavax upgraded on positive FDA panel at RBC Capital
As noted earlier, RBC Capital upgraded Dynavax to Outperform from Sector Perform. Analyst Matthew Eckler says that a positive report from an FDA panel on the company's HEPLISAV-B vaccine significantly lowers the vaccine's risk and could cause investors to become interested in the stock again. The analyst is upbeat on the vaccine's outlook and raised his price target on the shares to $26 from $7.
LVS Las Vegas Sands

07/18/17
STFL
07/18/17
NO CHANGE
STFL
Las Vegas Sands weakness creates buying opportunity, says Stifel
Stifel analyst Steven Wieczynski raised his estimates on Las Vegas Sands by about 4%, citing positive trends he's seen in Macau in the last six months and his belief that "Macau's fundamentals should continue to improve." The analyst says that the non-VIP trends in Macau continue to be strong and he thinks they "will remain healthy for the foreseeable future." He thinks that the recent pullback in the stock has created a buying opportunity.
07/17/17
GSCO
07/17/17
NO CHANGE
GSCO
Goldman says capital flow scrutiny could hurt sentiment on Macau gaming names
Goldman Sachs analyst Simon Cheung noted reports that Macau's largest junket operator has distributed a memo to its customers advising that police have launched large-scale investigations into questionable cross-border money transfers. To avoid scrutiny, some players may gamble less, which could hurt gross gaming revenue momentum in the near-term, Cheung tells investors. More important, perhaps, will be whether this issue will structurally impair the money transfer mechanism and that investors may become more concerned about the space. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO).
06/12/17
TLSY
06/12/17
NO CHANGE
TLSY
Macau estimates should continue to move higher, says Telsey Advisory
Telsey Advisory's contacts indicate the first 11 days of June's results indicate growth year-over-year of 29%-31% for the month, which is better than expected and supports the firm's view that estimates will continue to move higher heading into the quarterly reporting season. Telsey's analyst continues to see better leverage for Outperform rated Wynn Resorts (WYNN), with MGM Resorts (MGM) and Las Vegas Sands (LVS) also as beneficiaries.
05/19/17
JPMS
05/19/17
NO CHANGE
JPMS
Macau gaming regulator comments 'nothing new,' says JPMorgan
After local Chinese media quoted Paulo Chan, the director of Macau's gaming regulator, as having said that existing casino operators will have to "re-bid" for their concessions, JP Morgan analyst DS Kim said earlier that "this is nothing new" as he believes Chan was just clarifying legal terminology and statutory facts. Chan emphasized there isn't any new development regarding gaming concessions, which Kim thinks is the message he wanted to convey. Kim also said in a note issued prior to the open that his view remains that all six existing licenses will be renewed and no new license will be issued.
VALE Vale

03/31/17
BMOC
03/31/17
UPGRADE
BMOC
Market Perform
Vale upgraded on higher iron ore price outlook at BMO Capital
As noted earlier, BMO Capital upgraded Vale to Market Perform from Underperform. Analyst Edward Sterck upgraded the stock based on an increase in his iron ore price outlook. Target to $10 from $7.
03/31/17
BMOC
03/31/17
UPGRADE
BMOC
Market Perform
Vale upgraded to Market Perform from Underperform at BMO Capital
05/31/17
HSBC
05/31/17
UPGRADE
Target $10.5
HSBC
Buy
Vale upgraded to Buy from Hold at HSBC
HSBC analyst Jonathan Brandt upgraded Vale to Buy and raised his price target for the shares to $10.50 from $10. The recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield, Brandt tells investors in a research note.
05/31/17
05/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Donaldson (DCI) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying he sees "increasing evidence" the company's end-markets are exiting the multi-year trough and believes operating leverage should translate into above-average compound growth over the next few years. He recommends building positions in the stock during the second half of 2017. 2. VMware (VMW) upgraded to Outperform from Neutral at Baird with analyst Jason Noland citing the company's strategic shift to partner with firms rather than compete with the public cloud. 3. Akari Therapeutics (AKTX) upgraded to Neutral from Sell at Chardan. 4. Vale (VALE) upgraded to Buy from Hold at HSBC with analyst Jonathan Brandt saying the recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield. 5. Potbelly (PBPB) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson citing news that Chief Executive Officer Aylwin Lewis is resigning, as he believes new management could reinvigorate performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CLF Cliffs Natural

02/10/17
JPMS
02/10/17
NO CHANGE
Target $12
JPMS
Overweight
Cliffs Natural price target raised to $12 from $10 at JPMorgan
JPMorgan analyst Michael Gambardella raised his price target for Cliffs Natural Resources to $12 saying the company remains well positioned for higher earnings and cash flow. Domestic steel prices can be supported at the current higher, more sustainable level given reduced steel imports from trade cases and President Trump's focus on enforcing U.S. trade laws, Gambardella tells investors in a research note. He keeps an Overweight rating on Cliffs.
04/28/17
FBRC
04/28/17
UPGRADE
FBRC
Outperform
Cliffs Natural upgraded to Outperform from Market Perform at FBR Capital
07/31/17
AXIO
07/31/17
NO CHANGE
AXIO
Sell
Axiom says 'now is the time' to short U.S. Steel, maintains Sell rating
Axiom analyst Gordon Johnson II believes "now is the time" to short U.S. Steel (X) and Cliffs Natural (CLF) shares and to go underweight the U.S. steel sector, as he sees an increasing likelihood of an indefinite delay in the US Commerce Department's 232 steel tariff decision. He also thinks the contribution to China's GDP growth from commodity-intensive sectors may have peaked, he tells investors. The analyst keeps a Sell rating on U.S. Steel shares.
03/27/17
JPMS
03/27/17
NO CHANGE
Target $13
JPMS
Overweight
JPMorgan ups Cliffs target to $13 on higher iron ore prices
JPMorgan analyst Michael Gambardella raised his price target for Cliffs Natural Resources to $13 from $12 citing his firm's higher iron ore price forecasts. Chinese steel demand has proven to be more resilient, Gambardella tells investors in a research note. The analyst keeps an Overweight rating on Cliffs.
CMCSA Comcast
$39.52

0.09 (0.23%)

07/26/17
SBSH
07/26/17
DOWNGRADE
Target $52
SBSH
Sell
Dish downgraded to Sell from Buy at Citi
Citi analyst Jason Bazinet double downgraded Dish (DISH) to Sell from Buy and cut his price target for the shares to $52 from $94. The analyst believes Comcast (CMCSA) should acquire Verizon (VZ), and says such a deal would put "significant pressure" on Dish's equity since Verizon is viewed as the most likely Dish suitor.
07/26/17
SBSH
07/26/17
NO CHANGE
SBSH
Comcast should acquire Verizon for four reasons, says Citi
Citi analyst Jason Bazinet says Comcast (CMCSA) should acquire Verizon (VZ) for four reasons. Wireless would allow Comcast to extend Internet connectivity beyond the home, the deal would allow the company to push fiber deeper into neighborhoods, Verizon is apt to be the second biggest beneficiary of wireless consolidation, and Comcast could see upside if the tax code changes, Bazinet tells investors in a research note titled "Stars Are Aligning for Comcast + Verizon." The analyst sees the timing for a deal as right given Comcast's history of "trying to acquire assets that have fallen on difficult times" and the potential for a more amendable regulatory landscape under President Trump. Further, 2017 is the first year where Comcast's market capitalization exceeds Verizon's, the analyst adds. He estimates the pro forma combined company would generate $2.1B of annual synergies. Assuming a 20% premium for Verizon's equity, paid via 75% equity and 25% cash, Bazinet estimates Comcast shares would rise to $41. The stock closed yesterday up 28c to $39.75. Bazinet thinks Dish (DISH) could be the biggest loser should Comcast acquire Verizon, and he double downgraded the shares this morning to Sell from Buy.
07/31/17
JPMS
07/31/17
NO CHANGE
Target $450
JPMS
Overweight
Charter offer would likely have to be at least $500 per share, says JPMorgan
JPMorgan analyst Philip Cusick believes SoftBank (SFTBY) is one of the few companies that could offer a big enough price to take control of Charter Communications (CHTR). While a deal is not very likely, Softbank Chairman Masayoshi Son "is never to be counted out as a buyer," Cusick tells investors in a research note. He believes a Charter acquisition offer would likely have to be in the $500 per share or higher range. Charter shares in premarket trading are up $31.74 to $402 after the Wall Street Journal reported Friday night that SoftBank has interest in merging the company with Sprint. Cusick estimates annual synergies between Sprint (S) and Charter could be around $2B, with minimal cost to integrate versus a Sprint and T-Mobile (TMUS) merger "which would have more eventual cost savings but cost much more to integrate." A Sprint and Charter deal would not have a difficult regulatory review, the analyst believes. Cusick adds that if Charter looked like it was going to sell to Softbank, Comcast (CMCSA) would have to decide if it ever did want to buy Charter and "move more quickly with an even bigger premium."
07/13/17
TDSI
07/13/17
INITIATION
Target $51
TDSI
Buy
Comcast initiated with a Buy at TD Securities
TD Securities analyst Vince Valentini initiated Comcast with a Buy and a $51 price target.

TODAY'S FREE FLY STORIES

FL

Foot Locker

$34.88

-12.82 (-26.88%)

12:26
08/18/17
08/18
12:26
08/18/17
12:26
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

12:25
08/18/17
08/18
12:25
08/18/17
12:25
General news
FX Action: Risk-off? No, risk on. USD-JPY popped »

FX Action: Risk-off? No,…

CPN

Calpine

$14.87

1.365 (10.11%)

12:20
08/18/17
08/18
12:20
08/18/17
12:20
Options
Heavy trading in Calpine calls as shares rally »

Heavy trading in Calpine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$19.55

-0.07 (-0.36%)

12:19
08/18/17
08/18
12:19
08/18/17
12:19
Hot Stocks
U.S EEOC sues Macy's for disability discrimination »

The U.S. Equal Employment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

$NSD

NASDAQ Market Internals

12:17
08/18/17
08/18
12:17
08/18/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
08/18/17
08/18
12:16
08/18/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.36

0.35 (0.56%)

, XLU

Utilities SPDR

$54.48

0.3 (0.55%)

12:06
08/18/17
08/18
12:06
08/18/17
12:06
Technical Analysis
Technical View: S&P 500 edges above flatline, mid-session update »

The S&P 500 (SPX) was…

XLE

Energy Select Sector SPDR

$62.36

0.35 (0.56%)

XLU

Utilities SPDR

$54.48

0.3 (0.55%)

XLF

Financial Select Sector

$24.72

0.105 (0.43%)

XLK

Technology Select Sector SPDR

$57.33

0.2 (0.35%)

IYR

DJ US Real Estate Index Fund

$79.07

-0.7 (-0.88%)

XLP

Consumer Staples Sector SPDR

$55.25

-0.105 (-0.19%)

XLY

Consumer Discretionary Sector SPDR

$88.62

-0.07 (-0.08%)

SPY

SPDR S&P 500 ETF Trust

$243.52

0.43 (0.18%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$910.98

-15.98 (-1.72%)

, GOOGL

Alphabet Class A

$927.66

-16.61 (-1.76%)

12:04
08/18/17
08/18
12:04
08/18/17
12:04
Hot Stocks
Google launches new machine learning tool to track hate news »

In a blog post…

GOOG

Alphabet

$910.98

-15.98 (-1.72%)

GOOGL

Alphabet Class A

$927.66

-16.61 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

FMAO

Farmers & Merchants

$55.58

-0.17 (-0.30%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
Hot Stocks
Farmers & Merchants board declares two-for-one stock split »

Farmers & Merchants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$117.19

-6.7905 (-5.48%)

, CPN

Calpine

$14.83

1.33 (9.85%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
General news
On The Fly: Top stock stories at midday »

Stocks opened in negative…

DE

Deere

$117.19

-6.7905 (-5.48%)

CPN

Calpine

$14.83

1.33 (9.85%)

GPS

Gap

$22.43

-0.255 (-1.12%)

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

THC

Tenet

$14.04

1.385 (10.95%)

INFY

Infosys

$14.71

-1.22 (-7.66%)

FL

Foot Locker

$34.97

-12.73 (-26.69%)

FINL

Finish Line

$11.99

-0.17 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 18

    Aug

  • 23

    Aug

  • 06

    Sep

  • 06

    Sep

  • 22

    Nov

BC

Brunswick

$50.33

-0.995 (-1.94%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
Options
Call buyers in Brunswick as shares fall »

Call buyers in Brunswick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FL

Foot Locker

$34.98

-12.7201 (-26.67%)

11:59
08/18/17
08/18
11:59
08/18/17
11:59
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

RDUS

Radius Health

$35.42

-1.01 (-2.77%)

11:58
08/18/17
08/18
11:58
08/18/17
11:58
Hot Stocks
Biotech Growth acquires 60,000 more shares of Radius Health »

Biotech Growth NV…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

CVNA

Carvana

$15.12

-0.06 (-0.40%)

11:54
08/18/17
08/18
11:54
08/18/17
11:54
Hot Stocks
Breaking Hot Stocks news story on Carvana »

Carvana drops 3% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

CVNA

Carvana

$15.12

-0.06 (-0.40%)

11:53
08/18/17
08/18
11:53
08/18/17
11:53
Periodicals
Carvana mentioned cautiously by Copperfield Research »

Copperfield Research, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

11:51
08/18/17
08/18
11:51
08/18/17
11:51
Hot Stocks
Applied Materials CEO says technological shifts in industries to drive growth »

The CEO says has a good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.76

-12.94 (-27.13%)

11:50
08/18/17
08/18
11:50
08/18/17
11:50
Recommendations
Foot Locker analyst commentary  »

Foot Locker comp outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

11:50
08/18/17
08/18
11:50
08/18/17
11:50
General news
Fed's Kaplan sees GDP growth a little above 2% for 2017 »

Fed's Kaplan sees…

AMZN

Amazon.com

$960.57

-17.61 (-1.80%)

, ATVI

Activision Blizzard

$61.37

-1.52 (-2.42%)

11:49
08/18/17
08/18
11:49
08/18/17
11:49
Periodicals
Twitch acquires video indexing platform Clipmine, TechCrunch reports »

Twitch has acquired video…

AMZN

Amazon.com

$960.57

-17.61 (-1.80%)

ATVI

Activision Blizzard

$61.37

-1.52 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 05

    Sep

  • 07

    Sep

FL

Foot Locker

$34.82

-12.88 (-27.00%)

11:45
08/18/17
08/18
11:45
08/18/17
11:45
Downgrade
Foot Locker rating change  »

Wells doubts investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

11:42
08/18/17
08/18
11:42
08/18/17
11:42
Hot Stocks
Applied Materials CEO says much less volatility in chip sector »

The Applied Materials CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.94

-12.76 (-26.75%)

, NKE

Nike

$55.19

-2.27 (-3.95%)

11:41
08/18/17
08/18
11:41
08/18/17
11:41
Recommendations
Foot Locker, Nike, adidas analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$34.94

-12.76 (-26.75%)

NKE

Nike

$55.19

-2.27 (-3.95%)

ADDYY

adidas

$111.98

-1.52 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 03

    Oct

  • 04

    Oct

NBL

Noble Energy

$23.44

0.415 (1.80%)

11:40
08/18/17
08/18
11:40
08/18/17
11:40
Options
Notable put spread in Noble Energy »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ABCO

The Advisory Board

$51.05

-0.8 (-1.54%)

11:35
08/18/17
08/18
11:35
08/18/17
11:35
Options
Advisory Board put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTNB

root9B Technologies

$0.60

-0.1665 (-21.72%)

11:30
08/18/17
08/18
11:30
08/18/17
11:30
Hot Stocks
Breaking Hot Stocks news story on root9B Technologies »

root9B Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.